Loading...
Loading...
Analysts at Oppenheimer initiated coverage on
General Finance CorporationGFN with a Outperform rating. The target price for General Finance is set to $8. General Finance shares closed at $5.90 yesterday.
Analysts at UBS initiated coverage on
Jarden CorpJAH with a Buy rating. The target price for Jarden is set to $64. Jarden shares closed at $53.16 yesterday.
Analysts at Wunderlich initiated coverage on
Vista Outdoor IncVSTO with a Buy rating. The target price for Vista Outdoor is set to $55. Vista Outdoor shares closed at $45.22 yesterday.
Janney Capital initiated coverage on
Aldeyra Therapeutics IncALDX with a Buy rating. The target price for Aldeyra Therapeutics is set to $13. Aldeyra Therapeutics' shares closed at $6.87 yesterday.
Analysts at Mizuho Securities initiated coverage on
Rite Aid CorporationRAD with a Buy rating. The target price for Rite Aid is set to $10. Rite Aid shares closed at $8.63 yesterday.
Goldman Sachs initiated coverage on
Moneygram International IncMGI with a Neutral rating. The target price for Moneygram International is set to $11. Moneygram International's shares closed at $9.92 yesterday.
Analysts at Credit Suisse initiated coverage on
Loading...
Loading...
with a Outperform rating. The target price for Black Stone Minerals is set to $20. Black Stone Minerals' shares closed at $17.78 yesterday.
Raymond James initiated coverage on
Diplomat Pharmacy IncDPLO with a Outperform rating. The target price for Diplomat Pharmacy is set to $43. Diplomat Pharmacy shares closed at $39.07 yesterday.
Analysts at Northcoast Research initiated coverage on
Zeltiq Aesthetics IncZLTQ with a Buy rating. The target price for Zeltiq Aesthetics is set to $33. Zeltiq Aesthetics shares closed at $26.23 yesterday.
Buckingham Research initiated coverage on
Ulta Salon, Cosmetics & Fragrance, Inc.ULTA with a Buy rating. The target price for Ulta Salon Cosmetics is set to $182. Ulta Salon Cosmetics shares closed at $150.16 yesterday.
Loading...
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in